Sugarbaker Oncology Associates maintains an active program in treatment of gastric cancer. We offer the most experienced, multidisciplinary group of oncologists in the Washington D.C. area. Our treatment strategies include cytoreductive surgery, intraoperative intraperitoneal chemotherapy and hyperthermia. Our associates have numerous publications describing our innovative treatment strategies .
Gastric cancer is the second most frequently diagnosed cancer in the world.
The United States is fortunate in that the incidence of this dreadful disease is lower than many other countries. Systemic chemotherapy has proved to be of low, if any, value for these patients. At the same time, second-look laparotomy and autopsy studies reveal that even at death cancer remains confined to the abdomen in about half of patients. Within this group, there is a subset of patients with predominantly direct tumor extension to surrounding structures and peritoneal spread. These patients are in contrast to those with primary tumors with predominantly hematogenous metastases or a mixed pattern of dissemination.